Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
M.D. Anderson Cancer Center
Stemline Therapeutics, Inc.
Inmune Bio, Inc.
University of Florida
Eisai Inc.